End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
9.07
CNY
|
-0.66%
|
|
-0.11%
|
-14.51%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,590
|
3,660
|
6,684
|
11,783
|
6,631
|
5,354
|
Enterprise Value (EV)
1 |
3,376
|
3,923
|
6,998
|
11,421
|
5,810
|
4,089
|
P/E ratio
|
41.8
x
|
114
x
|
-554
x
|
15.8
x
|
12.4
x
|
118
x
|
Yield
|
-
|
0.44%
|
-
|
1.3%
|
1.66%
|
0.94%
|
Capitalization / Revenue
|
4.17
x
|
4.73
x
|
9
x
|
5.23
x
|
2.02
x
|
2.44
x
|
EV / Revenue
|
3.92
x
|
5.07
x
|
9.42
x
|
5.07
x
|
1.77
x
|
1.86
x
|
EV / EBITDA
|
23.9
x
|
45.8
x
|
107
x
|
12.1
x
|
8.24
x
|
23.8
x
|
EV / FCF
|
-110
x
|
-47.7
x
|
-346
x
|
20.3
x
|
10.5
x
|
18
x
|
FCF Yield
|
-0.91%
|
-2.1%
|
-0.29%
|
4.92%
|
9.55%
|
5.55%
|
Price to Book
|
1.05
x
|
1.36
x
|
2.51
x
|
3.45
x
|
1.74
x
|
1.15
x
|
Nbr of stocks (in thousands)
|
452,180
|
402,153
|
402,153
|
402,153
|
408,553
|
504,583
|
Reference price
2 |
7.940
|
9.100
|
16.62
|
29.30
|
16.23
|
10.61
|
Announcement Date
|
4/25/19
|
3/30/20
|
4/27/21
|
2/21/22
|
3/29/23
|
3/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
860.6
|
774.3
|
742.8
|
2,253
|
3,275
|
2,193
|
EBITDA
1 |
141.4
|
85.71
|
65.28
|
943.2
|
705.5
|
171.7
|
EBIT
1 |
90.22
|
31.74
|
7.301
|
884.4
|
619.2
|
48.93
|
Operating Margin
|
10.48%
|
4.1%
|
0.98%
|
39.26%
|
18.91%
|
2.23%
|
Earnings before Tax (EBT)
1 |
96.02
|
33.81
|
-7.078
|
886.7
|
612.9
|
51.39
|
Net income
1 |
83.8
|
32.47
|
-10.78
|
745
|
526.3
|
36.64
|
Net margin
|
9.74%
|
4.19%
|
-1.45%
|
33.07%
|
16.07%
|
1.67%
|
EPS
2 |
0.1900
|
0.0800
|
-0.0300
|
1.850
|
1.310
|
0.0900
|
Free Cash Flow
1 |
-30.7
|
-82.25
|
-20.25
|
562.5
|
555.2
|
227.1
|
FCF margin
|
-3.57%
|
-10.62%
|
-2.73%
|
24.97%
|
16.95%
|
10.36%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
59.64%
|
78.69%
|
132.27%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
75.5%
|
105.48%
|
619.77%
|
Dividend per Share
|
-
|
0.0400
|
-
|
0.3800
|
0.2700
|
0.1000
|
Announcement Date
|
4/25/19
|
3/30/20
|
4/27/21
|
2/21/22
|
3/29/23
|
3/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
264
|
314
|
-
|
-
|
-
|
Net Cash position
1 |
214
|
-
|
-
|
362
|
821
|
1,264
|
Leverage (Debt/EBITDA)
|
-
|
3.079
x
|
4.809
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-30.7
|
-82.2
|
-20.2
|
562
|
555
|
227
|
ROE (net income / shareholders' equity)
|
2.48%
|
1.06%
|
-0.4%
|
23.5%
|
12.9%
|
0.8%
|
ROA (Net income/ Total Assets)
|
1.46%
|
0.55%
|
0.14%
|
14.2%
|
7.19%
|
0.44%
|
Assets
1 |
5,748
|
5,924
|
-7,597
|
5,249
|
7,323
|
8,367
|
Book Value Per Share
2 |
7.540
|
6.700
|
6.630
|
8.490
|
9.330
|
9.250
|
Cash Flow per Share
2 |
0.3200
|
0.2500
|
0.1600
|
1.260
|
2.520
|
3.800
|
Capex
1 |
105
|
44.1
|
36.7
|
177
|
439
|
257
|
Capex / Sales
|
12.17%
|
5.69%
|
4.94%
|
7.86%
|
13.4%
|
11.73%
|
Announcement Date
|
4/25/19
|
3/30/20
|
4/27/21
|
2/21/22
|
3/29/23
|
3/24/24
|
|
1st Jan change
|
Capi.
|
---|
| -14.51% | 626M | | +2.46% | 102B | | -9.22% | 60.79B | | +74.76% | 48.86B | | +13.97% | 37.96B | | +4.56% | 32.37B | | +14.72% | 20.64B | | +11.17% | 16.58B | | +8.81% | 13.93B | | -3.19% | 13.25B |
Other Commodity Chemicals
|